Mediterranean diet study hopes to unlock prostate cancer clues

NCT ID NCT05590624

Recruiting now Knowledge-focused Sponsor: Case Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing how two types of Mediterranean diets (lower-carb or low-fat) affect metabolism in men with early prostate cancer who are not yet receiving treatment. Researchers will measure changes in prostate tissue and blood. The goal is to understand if diet can influence cancer-related metabolism, not to treat or cure the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Mediterranean-type diet (lower-carbohydrate or low-fat)
What this could lead to: If successful, this could point toward dietary recommendations that may help manage prostate cancer metabolism.
What could go wrong: This is a small, early exploratory study (30 men) looking at metabolic changes, not clinical outcomes like cancer progression. Results may not lead to clear dietary advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Case Comprehensive Cancer Center, Cleveland Clinic Foundation
RECRUITING

Cleveland, Ohio, 44195, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.